"Trump announces reforms on psychedelic drugs" (Fox News, uploaded April 18, 2026)This is a live/news segment from Fox News covering a White House event where President Donald Trump signs an executive order to reform and accelerate access to psychedelic drugs for medical research and treatment, with a strong focus on mental health issues like severe depression, PTSD, and addiction—especially among veterans.
Key Points from Trump's Announcement:The order directs the FDA to expedite reviews of psychedelics already designated as breakthrough therapies, reduce bureaucratic barriers, improve data-sharing with the Department of Veterans Affairs (VA), and enable faster rescheduling of approved substances.
Emphasis on the veteran suicide crisis: Trump notes that since 9/11, over 21 times more veterans have died by suicide than in combat.
He highlights promising research, including a Stanford study on ibogaine treatment for special operations veterans with traumatic brain injuries, which showed 80–90% reduction in depression and anxiety symptoms within one month.
Additional measures include expanding the "right to try" law for terminally ill patients and federal investments (e.g., $50 million mentioned for ibogaine research, alongside Texas Republican support).
Trump ties this to broader "Trump RX" drug pricing reforms aimed at cutting U.S. prescription costs by 50–80% via most-favored-nation pricing.
Speakers and Supporters Thanked:Trump credits several figures for their roles:Robert F. Kennedy Jr. (HHS Secretary) — stresses accelerating research for depression, PTSD, and addiction affecting millions, including over 6,000 veteran suicides annually.
FDA Commissioner Marty McCary — announces national priority review vouchers for psychedelics (potentially enabling approvals in weeks) and the first ibogaine investigational new drug clearance for human trials.
Dr. Mehmet Oz (CMS Administrator) and other officials like NIH Director Dr. J. Baracheria.
Personal stories from Congressman Morgan Luttrell and his brother, retired Navy SEAL Marcus Luttrell, who describe life-changing benefits from ibogaine (e.g., regaining a sense of life after years of struggle).
Joe Rogan and others advocate for ending federal prohibition on psychedelic medicine, honoring indigenous knowledge, and noting high remission rates (30–40% for PTSD where traditional treatments often fail).
Additional Context from the Event:Speakers discuss the potential of these therapies as rapid-acting options when antidepressants (with only 20–30% response rates) fall short. They stress the need for controlled medical administration due to side effects, continued safety research through NIH and ARPA-H, and broader applications (e.g., addiction treatment, where ibogaine has reportedly helped 80–90% of opiate users in some contexts).The event is framed as a historic step forward in mental health innovation, combining Trump administration policy with input from advocates, researchers, and high-profile supporters like Rogan.Overall Tone: Positive and urgent, positioning the reforms as a breakthrough for veterans and patients failed by current systems, while balancing innovation with safety and oversight.The video runs about 50 minutes and includes speeches, the signing, and commentary. It's a straightforward Fox News broadcast of the live event with minimal added analysis in the core segment.
u/#supplies
Big Mike? pfft... I'll show you a BIG Mike!!!
Or, a big mic.
u/#sassypopcorn
Coming to America, in case you forgot the reference...
KEK.
It certainly does! 😉
Grok Video Summary:
"Trump announces reforms on psychedelic drugs" (Fox News, uploaded April 18, 2026)This is a live/news segment from Fox News covering a White House event where President Donald Trump signs an executive order to reform and accelerate access to psychedelic drugs for medical research and treatment, with a strong focus on mental health issues like severe depression, PTSD, and addiction—especially among veterans.
Key Points from Trump's Announcement:The order directs the FDA to expedite reviews of psychedelics already designated as breakthrough therapies, reduce bureaucratic barriers, improve data-sharing with the Department of Veterans Affairs (VA), and enable faster rescheduling of approved substances. Emphasis on the veteran suicide crisis: Trump notes that since 9/11, over 21 times more veterans have died by suicide than in combat. He highlights promising research, including a Stanford study on ibogaine treatment for special operations veterans with traumatic brain injuries, which showed 80–90% reduction in depression and anxiety symptoms within one month. Additional measures include expanding the "right to try" law for terminally ill patients and federal investments (e.g., $50 million mentioned for ibogaine research, alongside Texas Republican support). Trump ties this to broader "Trump RX" drug pricing reforms aimed at cutting U.S. prescription costs by 50–80% via most-favored-nation pricing.
Speakers and Supporters Thanked:Trump credits several figures for their roles:Robert F. Kennedy Jr. (HHS Secretary) — stresses accelerating research for depression, PTSD, and addiction affecting millions, including over 6,000 veteran suicides annually. FDA Commissioner Marty McCary — announces national priority review vouchers for psychedelics (potentially enabling approvals in weeks) and the first ibogaine investigational new drug clearance for human trials. Dr. Mehmet Oz (CMS Administrator) and other officials like NIH Director Dr. J. Baracheria. Personal stories from Congressman Morgan Luttrell and his brother, retired Navy SEAL Marcus Luttrell, who describe life-changing benefits from ibogaine (e.g., regaining a sense of life after years of struggle). Joe Rogan and others advocate for ending federal prohibition on psychedelic medicine, honoring indigenous knowledge, and noting high remission rates (30–40% for PTSD where traditional treatments often fail).
Additional Context from the Event:Speakers discuss the potential of these therapies as rapid-acting options when antidepressants (with only 20–30% response rates) fall short. They stress the need for controlled medical administration due to side effects, continued safety research through NIH and ARPA-H, and broader applications (e.g., addiction treatment, where ibogaine has reportedly helped 80–90% of opiate users in some contexts).The event is framed as a historic step forward in mental health innovation, combining Trump administration policy with input from advocates, researchers, and high-profile supporters like Rogan.Overall Tone: Positive and urgent, positioning the reforms as a breakthrough for veterans and patients failed by current systems, while balancing innovation with safety and oversight.The video runs about 50 minutes and includes speeches, the signing, and commentary. It's a straightforward Fox News broadcast of the live event with minimal added analysis in the core segment.